Gabelli & CO Investment Advisers, Inc. Sc Pharmaceuticals Inc. Transaction History
Gabelli & CO Investment Advisers, Inc.
- $510 Million
- Q3 2025
A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 307,800 shares of SCPH stock, worth $1.75 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
307,800Holding current value
$1.75 Million% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding SCPH
# of Institutions
117Shares Held
40.5MCall Options Held
835KPut Options Held
11.9K-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million1.17% of portfolio
-
Rubric Capital Management LP New York, NY5.1MShares$28.9 Million0.47% of portfolio
-
Weiss Asset Management LP Boston, MA2.88MShares$16.3 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$12.3 Million0.0% of portfolio
-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct2.15MShares$12.2 Million0.01% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...